Skip to content
Bills from the 2025–26 session

Senate Bill 492

Coverage of nonopioid drug alternatives for the treatment and management of pain

Topics: Drugs, Health Services, Department of: Administration, Insurance: Commissioner, Office of, Insurance: Health, Public employee: Group insurance, United States: Food and Drug Administration

Stopped in committee

The voted on it but didn't recommend it, so the full Senate never voted. The last day for votes this session was Mar 19, 2026. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Oct 2, 2025

  2. Committee, stopped here

    Stopped here. The committee didn't recommend it.

  3. Senate vote, not reached

  4. Assembly vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Mar 23, 2026: “Failed to pass pursuant to ⁠”

It sat with the Senate Committee on Mental Health, Substance Abuse Prevention, Children and Families.

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

Embed this on your site

Paste this code into your page. The card shows the latest record each time it loads. Preview the card

The same bill was also filed in the Assembly as AB 499. That version died when the session ended.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill requires health care insurance plans and self-insured governmental health plans that provide drug coverage to develop and implement a pain management access plan to ensure adequate coverage and access to a broad spectrum of pain management alternatives to opioid drugs. Under the bill, the health care plan or self-insured plan must provide coverage for at least two prescription medication treatment options that are approved by the U.S. Food and Drug Administration for the treatment or management of pain and are not schedule I, II, or III controlled substances. The health care plan or self-insured plan must also provide coverage for at least three alternative nonpharmacological treatment modalities. The bill prohibits the health care plan or self-insured plan from establishing utilization controls for clinically appropriate, FDA-approved nonopioid drugs or drug products that are more restrictive or extensive than utilization controls applicable to an opioid or narcotic drug. Also under the bill, the health care plan or self-insured plan must provide information about the pain management access plan to enrollees and health care providers and make the plan publicly available on its website.

The bill prohibits the Department of Health Services from disadvantaging or discouraging the inclusion on its preferred drug list of a nonopioid drug that is approved by the FDA for the treatment or management of pain relative to the inclusion of an opioid or narcotic drug for the treatment or management of pain.

Read the full summary

This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats.

Who's behind it

2 senators are its ⁠. 1 is a Democrat and 1 is a Republican.

11 more lawmakers ⁠.

See all 13 names

Authors (2)

Signed on in support (11)

Versions and amendments

Every text the Legislature printed for this bill, including proposed changes. Each opens on the Legislature's site.

How lawmakers voted

There was one vote on this bill.

Senate vote

Failed, 2 to 3 · Jan 22, 2026

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3”. Official record · This vote on its own page

What happened

  1. Mar 23, 2026

    The session ended, and the bill died with it.

  2. Jan 22, 2026

    “Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3” (the official wording)

  3. Jan 22, 2026

    The committee voted on it.

  4. Oct 8, 2025

    The committee held a public hearing.

  5. Oct 7, 2025

    “Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes” (the official wording)

  6. Oct 2, 2025

    Sent to the Senate Committee on Mental Health, Substance Abuse Prevention, Children and Families.

  7. Oct 2, 2025

    Introduced in the Senate.

See the official record, word for word
  1. Oct 2, 2025 · Senate

    Introduced by Senators James, Dassler-Alfheim and Keyeski; cosponsored by Representatives Moses, Armstrong, Behnke, Duchow, Gundrum, Knodl, Melotik, Mursau, O'Connor, Wichgers and Murphy

  2. Oct 2, 2025 · Senate

    Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families

  3. Oct 7, 2025 · Senate

    Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes

  4. Oct 8, 2025 · Senate

    Public hearing held

  5. Dec 16, 2025 · Senate

    Senate Amendment 1 offered by Senator James

  6. Jan 22, 2026 · Senate

    Senator Keyeski withdrawn as a coauthor

  7. Jan 22, 2026 · Senate

    Executive action taken

  8. Jan 22, 2026 · Senate

    Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3

  9. Jan 22, 2026 · Senate

    Available for scheduling

  10. Mar 23, 2026 · Senate

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote